glaxo-memo-shows-drug-industry-lobbying- Bloomberg News

Status
Not open for further replies.

KjAthena

Vaping Master
ECF Veteran
Verified Member
Aug 10, 2013
3,803
5,625
Tampa Bay
http://www.bloomberg.com/news/2014-02-19/on-e-cigarettes.html?cmpid=yhoo

[h=1]Lobbying on E-Cigarettes[/h]

GlaxoSmithKline Plc (GSK) is pushing for more stringent regulation of electronic cigarettes, which compete with its Nicorette gum and other smoking cessation products, according to e-mails from a company executive.
Europe should follow the lead of the U.K., which plans to require e-cigarettes to be licensed as medicines much the way other nicotine-replacement therapy products are, wrote Sophie Crousse, the Brussels-based vice president of European public affairs for Glaxo’s consumer health-care division.
Related: Glaxo Sees 2014 Profit, Sales Rising on New Products
“We believe in responsible and proportionate regulation for all nicotine-containing products as medicinal products,” Crousse said in an e-mail dated Oct. 30. The message and other documents were made public last week through a freedom of information request made to the health and consumer affairs division of the European Commission.
The commission is revising the Tobacco Products Directive to regulate products such as e-cigarettes that don’t contain tobacco, yet are linked to tobacco use. E-cigarettes, which Euromonitor International Plc estimates will generate $7 billion in sales by the end of this year, compete with quit-smoking products sold by pharmaceutical companies including Glaxo, Johnson & Johnson (JNJ) and Novartis AG.

<...>

 
Last edited by a moderator:

DrMA

Ultra Member
ECF Veteran
Jan 26, 2013
2,989
9,887
Seattle area
Let's see: ecigs show up on the market and work better than all BP NRT products combined. Options for BP: 1) embrace the new tech and try to adapt to the new reality of the marketplace 2) use the Kodak approach and try to bury them.

If we're lucky, this will be BP's Kodak moment when it comes to smoking cessation. As in what happened to Kodak when the digital age started.
 

soba1

Ultra Member
ECF Veteran
May 27, 2013
2,257
1,949
65
Van Nuys Ca., USA
Let's see: ecigs show up on the market and work better than all BP NRT products combined. Options for BP: 1) embrace the new tech and try to adapt to the new reality of the marketplace 2) use the Kodak approach and try to bury them.

If we're lucky, this will be BP's Kodak moment when it comes to smoking cessation. As in what happened to Kodak when the digital age started.

The shift has begun. It's only good if they control it
 

Sundodger

Super Member
ECF Veteran
Sep 22, 2013
351
964
All 57 States
What disturbs me is that these companies are not hurting. Their products are still profitable. They just want more, all of it. No competition. Drug companies could come up with a better product, they could compete. Their chicken. It's easier to develop regulations.

Still a boodle of bucks going to go down the drain for them with vaping (let alone what the gubmint is going to lose). The smoking cessation products, the COPD prescriptions, blood pressure meds, teeth whiting products, the Dr.'s that support them with writing those prescriptions will see less bronchitis and other smoking related visits and last and saddest is the cancer treatment industry will see a loss of revenue.
If they really, REALLY cared about us they would just take the losses and say good job, wish we had thought of it.
 

rothenbj

Vaping Master
Supporting Member
ECF Veteran
Verified Member
Jul 23, 2009
8,285
7,707
Green Lane, Pa
“Safety is our number one priority and we support the smoker’s right to choose from a selection of products that have well established safety and efficacy profile in helping them quit smoking,” Simon Steel, a spokesman for London-based Glaxo, said in an e-mailed statement. “All nicotine-containing products including e-cigarettes should be reviewed and regulated to the same standard of safety.”[/quote

Yes, $$$$$$afety is their number one priority. Sorry if I stuttered.

I agree. Ifc BP would stop making health claims about their products, they could sell them as consumer products. Improve them and lower the price and they still couldn't compete.
 
Last edited:

graffiti

Senior Member
ECF Veteran
Verified Member
Jan 23, 2014
231
247
CT
It's over for small vendors.

The pharma and tobacco company products will survive, and some off-shore internet business will survive, but I really don't think that anyone in the US mod/juice industry has the money to fight these bans. Even pooling resources wouldn't hold a candle to the amount of money somebody like GSK could spend if they want to.
 

sonicdsl

Wandering life's highway
Supporting Member
ECF Veteran
Verified Member
Aug 11, 2011
17,744
19,245
FiKy0ka.png
 
Status
Not open for further replies.

Users who are viewing this thread